344 related articles for article (PubMed ID: 26000810)
1. Botulinum toxin A in the treatment of trigeminal neuralgia.
Xia JH; He CH; Zhang HF; Lian YJ; Chen Y; Wu CJ; Ma YQ
Int J Neurosci; 2016; 126(4):348-53. PubMed ID: 26000810
[TBL] [Abstract][Full Text] [Related]
2. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
Zúñiga C; Piedimonte F; Díaz S; Micheli F
Clin Neuropharmacol; 2013; 36(5):146-50. PubMed ID: 24045604
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin and intractable trigeminal neuralgia.
Türk U; Ilhan S; Alp R; Sur H
Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
[TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
Zúñiga C; Díaz S; Piedimonte F; Micheli F
Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
Burmeister J; Holle D; Bock E; Ose C; Diener HC; Obermann M
Trials; 2015 Dec; 16():550. PubMed ID: 26634453
[TBL] [Abstract][Full Text] [Related]
8. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
Morra ME; Elgebaly A; Elmaraezy A; Khalil AM; Altibi AM; Vu TL; Mostafa MR; Huy NT; Hirayama K
J Headache Pain; 2016 Dec; 17(1):63. PubMed ID: 27377706
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.
Li S; Lian YJ; Chen Y; Zhang HF; Ma YQ; He CH; Wu CJ; Xie NC; Zheng YK; Zhang Y
J Headache Pain; 2014 Jun; 15(1):43. PubMed ID: 24952600
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.
Hu Y; Guan X; Fan L; Li M; Liao Y; Nie Z; Jin L
J Headache Pain; 2013 Aug; 14(1):72. PubMed ID: 23964790
[TBL] [Abstract][Full Text] [Related]
12. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
Zhang H; Lian Y; Ma Y; Chen Y; He C; Xie N; Wu C
J Headache Pain; 2014 Sep; 15(1):65. PubMed ID: 25263254
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin in trigeminal neuralgia.
Castillo-Álvarez F; Hernando de la Bárcena I; Marzo-Sola ME
Med Clin (Barc); 2017 Jan; 148(1):28-32. PubMed ID: 27743594
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices.
Tangney T; Heydari ES; Sheldon BL; Shetty A; Argoff CE; Khazen O; Pilitsis JG
Stereotact Funct Neurosurg; 2022; 100(5-6):314-320. PubMed ID: 35944492
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up.
Türk Börü Ü; Duman A; Bölük C; Coşkun Duman S; Taşdemir M
Medicine (Baltimore); 2017 Sep; 96(39):e8133. PubMed ID: 28953646
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia.
Liu J; Xu YY; Zhang QL; Luo WF
Pain Res Manag; 2018; 2018():7365148. PubMed ID: 29849847
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y
Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
[TBL] [Abstract][Full Text] [Related]
18. Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study.
Zhang H; Lian Y; Xie N; Chen C; Zheng Y
J Headache Pain; 2017 Aug; 18(1):81. PubMed ID: 28799056
[TBL] [Abstract][Full Text] [Related]
19. Topical Review: Potential Use of Botulinum Toxin in the Management of Painful Posttraumatic Trigeminal Neuropathy.
Moreau N; Dieb W; Descroix V; Svensson P; Ernberg M; Boucher Y
J Oral Facial Pain Headache; 2017 Winter; 31(1):7-18. PubMed ID: 28118416
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
Shehata HS; El-Tamawy MS; Shalaby NM; Ramzy G
J Headache Pain; 2013 Nov; 14(1):92. PubMed ID: 24251833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
